Delivery Order SPE2DB22D3301-SPE2DB24FZ4PW

Award Date 9/18/24
Potential Completion Date 9/19/24
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 120 tablets of Alfuzosin Hydrochloride Extended Release 10 mg, a medication used to treat an enlarged prostate. The contract has a firm fixed price of $2,107.38 and a completion date of May 28, 2025. This delivery order is not set aside and was awarded on May 27, 2025....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,173.75 firm fixed-price contract is for the delivery of 120 tablets of Alfuzosin Hydrochloride Extended-Release 10 mg, a medication used to treat benign prostatic hyperplasia. The contract has a completion date of February 15, 2024 and was awarded on February 14, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 120-count tablets of Alfuzosin HCl ER 10 mg, a medication used to treat an enlarged prostate. The total ceiling value of the contract is $13,161.86, and it has a completion date of December 26, 2023. The contract is a firm-fixed-price delivery order...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract, valued at $1,878.00, is for the supply of 120 tablets of the prescription medication Alfuzosin Hydrochloride Extended Release 10 mg. The contract has a firm fixed price and runs until July 25, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to various government...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $2,243.62 order is for the provision of 90 units of Alfuzosin Hydrochloride Extended Release 10 mg tablets. This delivery order is part of AmerisourceBergen's existing indefinite delivery contract with DLA to supply pharmaceuticals and medical supplies in...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,790.16, is for the delivery of Alfuzosin HCL ER 10 mg tablets, a medication used to treat symptoms of an enlarged prostate. The contract has a firm fixed price and runs through March 13, 2025. It is not designated as a set-aside contract. AmerisourceBergen also holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,786.17 firm fixed-price delivery order is for the supply of 120 tablets of Alfuzosin HCL ER 10 mg, a medication used to treat the symptoms of an enlarged prostate. The contract has an ultimate completion date of July 12, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Alfuzosin Hydrochloride Extended-Release 10 mg Tablets. The contract has a ceiling value of $1,677.32 and is a firm-fixed-price contract type. The ultimate completion date for this order is September 26, 2024. AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,063.19, is for the delivery of Alfuzosin ER 10 mg tablets, a medication used to treat an enlarged prostate. The contract is a Firm Fixed Price Delivery Order with a period of performance through February 3, 2025. The contract is not designated as a set-aside....
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,626.79, is for the delivery of 120 tablets of Alfuzosin HCl ER 10 mg, a medication used to treat the symptoms of an enlarged prostate. The contract has a completion date of March 6, 2025 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FZ4PW
    Delivery Order

This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The $1,956.25 firm fixed price contract is for the supply of 120 tablets of 10 mg Alfuzosin Hydrochloride Extended-Release tablets, a medication used to treat symptoms of an enlarged prostate. The contract has an ultimate completion date of September 19, 2024. AmerisourceBergen, a large pharmaceutical distributor, has been awarded numerous indefinite delivery contracts by the DLA and other federal agencies to provide a wide range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other government healthcare initiatives. This contract award does not utilize any set-aside designations.

Generated 12/18/24, 9:31 AM